MediWound Ltd.
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-8.98-27.8313.825.99
Price/Sales ratio
15.6110.455.433.83
Earnings per Share (EPS)
$-1.93$-0.62$1.25$2.89

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-7.01-8.37-5.30-4.79-104.1422.66-10.48-4.74-3.43-13.64-183.4522.66
Price/Sales ratio
510.90307.9364.2442.5432.362.654.622.702.534.90146.8532.36
Price/Book Value ratio
3.087.8812.8811.0312.265.5513.84-14.036.162.901.80K12.26
Price/Cash Flow ratio
-8.02-9.44-6.08-6.45-9.0510.16-14.60-7.21-5.66-8.75-185.5210.16
Price/Free Cash Flow ratio
-7.83-9.25-5.83-6.05-8.6711.23-12.87-6.83-5.40-5.41-179.9711.23
Price/Earnings Growth ratio
-0.27-1.160.34-0.491.08-0.040.02-0.11-0.260.160.070.07
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-975.28%-319.13%-38.51%36.77%38.60%62.72%34.66%36.91%49.68%19.14%32.14%62.72%
Operating Profit Margin
-8272.97%-3531.94%-1293.64%-548.35%-116.43%14.13%-40.61%-47.22%-31.49%-81.82%-67.17%-116.43%
Pretax Profit Margin
-7287.64%-3605.82%-1212.13%-582.25%-166.56%6.49%-42.62%-56.91%-73.67%-34.95%-79.96%-166.56%
Net Profit Margin
-7287.64%-3675.20%-1212.13%-887.37%-31.07%11.69%-44.11%-57.02%-73.96%-35.94%-80.04%11.69%
Effective Tax Rate
13.52%-3.97%6.72%-58.22%171.03%-79.96%-3.50%-0.19%-0.39%-2.83%-0.10%-0.10%
Return on Assets
-26.53%-42.05%-52.80%-50.18%-2.99%9.15%-30.90%-68.63%-39.18%-10.10%-57.02%9.15%
Return On Equity
-44.02%-94.11%-243.05%-230.23%-11.78%24.51%-132.02%295.74%-179.57%-21.25%2027.61%-11.78%
Return on Capital Employed
-31.87%-44.86%-66.33%-35.36%-13.03%14.86%-38.76%-124.36%-21.98%-27.48%-69.89%14.86%
Liquidity Ratios
Current Ratio
17.569.676.247.646.683.433.16N/AN/AN/A2.713.43
Quick Ratio
17.219.356.097.296.333.273.001.283.634.320.553.27
Cash ratio
6.528.165.366.631.370.692.101.032.811.09N/A0.69
Days of Sales Outstanding
2.83K1.76K641.67502.45780.0147.1546.4034.82128.5586.3189.1889.18
Days of Inventory outstanding
186.23248.50142.75436.24293.6749.6835.4229.2153.7468.7549.6549.68
Operating Cycle
3.02K2.01K784.43938.701.07K96.8481.8364.03182.30155.0771.6496.84
Days of Payables Outstanding
159.10162.72246.26751.97474.60125.2876.80114.25154.86133.5594.16125.28
Cash Conversion Cycle
2.86K1.85K538.16186.72599.08-28.435.02-50.2227.4421.527.267.26
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.94N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A16.26N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.36N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
-6.6518.1466.7332.514.58-8.47-10.62N/AN/AN/A-15.08-8.47
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
1.652.234.604.583.932.674.27-4.304.582.1017.263.93
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-63.67-32.61-10.55-6.59-3.570.26-0.31-0.37-0.44-0.56-0.79-3.57
Free Cash Flow / Operating Cash Flow Ratio
1.021.021.041.061.040.901.131.051.041.611.030.90
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A